Gilead Sciences
For more than 35 years, we've been tackling some of the world’s greatest public health challenges. We've revolutionized HIV treatment and prevention, delivered a cure for hepatitis C and made advancements in therapies for viral diseases and certain cancers.
Gilead Sciences: Company
Learn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information.
Gilead Foundation: Building Health Equity in Communities - Gilead …
The Gilead Foundation builds health equity with employee matching, community donations & funding to address social determinants of health including education. Science Therapeutic Areas
Gilead Strengthens Early Pipeline in Oncology and ... - Gilead …
May 9, 2023 · Through the acquisition, Gilead gains rights to a portfolio of small molecule inhibitors targeting PARP1 for oncology and MK2 for inflammatory diseases that could enter clinical trials later this year.
Gilead Sciences Completes Acquisition of MYR GmbH
Mar 4, 2021 · FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire MYR GmbH for up to approximately €1.45 billion in aggregate cash consideration.
Mexico | Gilead - Gilead Sciences
Gilead Sciences Mexico, S. de R.L. de C.V. Phone: +52 55 53 50 49 00. Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
Gilead Sciences Expands Liver Portfolio With Acquisition of …
Feb 12, 2024 · The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver portfolio and aligns with its long-standing commitment …
Corporate Giving at Gilead Sciences
Gilead: To build a healthier world, our Corporate Giving program directs funding to remove barriers to care, expand healthcare capacity & advocate for social change.
Virology, Inflammation, & Oncology Pipeline | Gilead - Gilead …
Aug 8, 2024 · We are advancing new treatments to help address the needs of people living with inflammatory and fibrotic diseases, including primary biliary cholangitis (PBC), inflammatory bowel disease, lupus and metabolic dysfunction-associated steatohepatitis (MASH).
Gilead and Kite Oncology Demonstrate Transformative ... - Gilead …
Nov 3, 2022 · Gilead, the Gilead logo, Kite and the Kite logo are trademarks ofGilead Sciences, Inc., or its related companies. For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.